Maravai LifeSciences

💡 Maravai LifeSciences' Science & Innovation Office was proud to sponsor Nkaeye Thapelo from South African Medical Research Council in Cape Town, South Africa to attend the recent mRNA manufacturing course held at the National Center for Therapeutics Manufacturing (NCTM) located on the Texas A&M University campus. ⭐ Watch the video below to hear from Nkaeye about her experience attending the course and the importance of having the involvement of companies like Maravai LifeSciences and TriLink BioTechnologies, part of Maravai LifeSciences to help democratize science around the world. #Education #Innovation #GlobalCollaboration #mRNAmanufacturing #Biotech

⭐ This Monday's #MiracleMaker is Shelby Yuhas, a Scientist at Glen Research!   After graduating from The Johns Hopkins University in 2020, Shelby was doing postdoctoral research with small molecule inhibitors for DNA repair enzymes when she heard about a Scientist role with Glen Research. Bringing her vast structural and analytical experience in everything from enzyme kinetics, organic synthesis, cell biology, phosphonamidites, chromatographic techniques, and more, Shelby joined the Glen team in May 2021 and has been helping colleagues and customers to use Glen products and solve problems.   Want to be a #MiracleMaker? Explore open roles below: https://lnkd.in/et6kyMar #MiracleMakers #EmployeeSpotlight #Innovators #Innovation

💡 Maravai LifeSciences' Science & Innovation Office was proud to sponsor Nkaeye Thapelo from South African Medical Research Council in Cape Town, South Africa to attend the recent mRNA manufacturing course held at the National Center for Therapeutics Manufacturing (NCTM) located on the Texas A&M University campus. ⭐ Watch the video below to hear from Nkaeye about her experience attending the course and the importance of having the involvement of companies like Maravai LifeSciences and TriLink BioTechnologies, part of Maravai LifeSciences to help democratize science around the world. #Education #Innovation #GlobalCollaboration #mRNAmanufacturing #Biotech

📢 𝗔𝗹𝗽𝗵𝗮𝘇𝘆𝗺𝗲 𝗶𝘀 𝗲𝘅𝗰𝗶𝘁𝗲𝗱 𝘁𝗼 𝗶𝗻𝘁𝗿𝗼𝗱𝘂𝗰𝗲 𝗼𝘂𝗿 𝗻𝗲𝘄 𝗽𝗿𝗼𝗱𝘂𝗰𝘁, 𝗦𝗼𝗹𝗼𝗦𝗰𝗿𝗶𝗽𝘁 𝗥𝗡𝗔 𝗣𝗼𝗹𝘆𝗺𝗲𝗿𝗮𝘀𝗲! Test the difference our novel RNA Polymerase can make in your experiments. Experience up to 85% reduction of unwanted dsRNA byproducts while retaining IVT yields, efficiency, and key mRNA quality attributes!  📦 𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗬𝗼𝘂𝗿 𝗧𝗿𝗶𝗮𝗹 𝗦𝗮𝗺𝗽𝗹𝗲 𝗧𝗼𝗱𝗮𝘆! 𝗔𝘃𝗮𝗶𝗹𝗮𝗯𝗹𝗲 𝗶𝗻 𝟮 𝗰𝗼𝗻𝗰𝗲𝗻𝘁𝗿𝗮𝘁𝗶𝗼𝗻𝘀: •0.2 mg/mL •1.0 mg/mL (5x concentrated) --> supplied with a dilution buffer so you can find your ideal concentration.   👉 𝗖𝗹𝗮𝗶𝗺 𝘆𝗼𝘂𝗿 𝘁𝗿𝗶𝗮𝗹 𝘀𝗮𝗺𝗽𝗹𝗲 𝗯𝘆 𝗰𝗹𝗶𝗰𝗸𝗶𝗻𝗴 𝘁𝗵𝗲 𝗹𝗶𝗻𝗸 𝗯𝗲𝗹𝗼𝘄, 𝗮𝗻𝗱 𝘀𝘁𝗮𝗿𝘁 𝗺𝗮𝗸𝗶𝗻𝗴 𝗴𝗿𝗼𝘂𝗻𝗱𝗯𝗿𝗲𝗮𝗸𝗶𝗻𝗴 𝗱𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝗶𝗲𝘀 𝘁𝗼𝗱𝗮𝘆! https://lnkd.in/eHuWU_nt

Our seminar Building momentum in mRNA — From discovery through clinical trials is coming to Belgium and France! Interested to learn more about the latest mRNA innovations? Are you looking for opportunities to network with industry experts? Save the date and join us in Brussels or Paris! 🗓️📍 Featured speakers include: Manuel Vega PhD, CEO at AGS Therapeutics, Ashish Dhir PhD, Head of RNA at 4basebio, Kate Broderick PhD, and Victoria Smith PhD, from TriLink BioTechnologies, part of Maravai LifeSciences. They'll be sharing their insights and experiences into the latest advances in the mRNA field. Agenda: 🕑 14:00 to 17:00: Speaker presentations 🤝 17:00 Networking Hour 📍Brussels, September 24th, register here: https://lnkd.in/efNs7UU7 📍Paris, September 26th, register: https://lnkd.in/eyBfCQU4 Register now to secure your spot! #mRNA #LifeSciences #SeminarSeries #Innovation

⭐ This Monday's #MiracleMaker is Thomas Penrose, a Fermentation Supervisor at Alphazyme LLC!   Raised in Jupiter, Florida, Thomas fell in love with science early. After completing his bachelor's degree in molecular biology at Indian River State College, he was committed to doing something that would give back to the world, and in 2019 he found Alphazyme. Inspired by their mission and leadership, Thomas joined the team and is now the Fermentation Supervisor. He has been an integral part of building the business – literally and figuratively!   Want to be a #MiracleMaker? Explore open roles below: https://lnkd.in/et6kyMar #MiracleMakers #EmployeeSpotlight #Innovators #Innovation

In this piece from Contagion_Live, Maravai LifeSciences' Chief Innovation Officer, Dr. Kate Broderick, shares the critical role of CleanCap® mRNA capping technology—a key component in 75% of approved mRNA COVID-19 vaccines.   In this article, Dr. Broderick explains how mRNA capping acts as both a protective shield and a guiding mechanism for mRNA molecules, ensuring they reach their cellular targets effectively. She also highlights the wide-ranging applications of this technology, including its impact on cancer vaccine development and CRISPR advancements.   Learn how TriLink BioTechnologies, part of Maravai LifeSciences, is leading the charge with their innovative CleanCap® technology, paving the way for more stable and efficient vaccines.   👉 Explore the full article here to discover how this technology is shaping the future of pharmaceutical development: https://lnkd.in/eFBqgKiF #Biotech #mRNA #Vaccines #HealthcareInnovation #FutureOfMedicine #Pharma #CleanCap

CEO Trey Martin and CFO Kevin Herde will participate in a fireside chat at the Morgan Stanley Healthcare Conference in NYC on September 5th, at 4:50 PM EDT.   You can listen to the event live and access the replay at: https://lnkd.in/gEEjcq-P #LifeSciences #MorganStanleyHealthcare #Healthcare #Biotech

Join our CEO, Trey Martin, and CFO, Kevin Herde, for a fireside chat at the Wells Fargo Healthcare Conference in Boston on September 4th, at 9:30am EDT.   The session will be streamed live, and recorded at:  https://lnkd.in/gahkzfta   #LifeSciences #WellsFargoHealthcare #Healthcare #Biotech

Cygnus Technologies, LLC, TriLink BioTechnologies, part of Maravai LifeSciences, both part of Maravai LifeSciences have collaborated to launch Cygnus’ AccuRes™ Host Cell DNA Quantification Kits. Together, the companies have leveraged state-of-the-art technologies and reagents to develop an assay with unparalleled sensitivity and specificity to help produce safer, more stable biotherapeutics that surpass regulatory standards. Learn more about this exciting collaboration here: https://lnkd.in/gtqJkjx7